您当前的位置：
首页 >
文章列表页 >
Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)
Guideline and Consensus | 更新时间：2026-02-09

    • Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)

    • “World Health Organization data show that breast cancer is one of the common cancers and the main causes of death among women. The breast cancer Professional Committee of China Anti Cancer Association has continuously updated the guidelines since they were first formulated in 2007. The 2026 version of the guidelines includes new ideas, new tools, new norms and new programs on the basis of the 2024 version, providing guidance for the prevention, control, diagnosis and treatment of breast cancer.”
    • China Oncology   Vol. 35, Issue 12, Pages: 1157-1255(2025)

    • DOI：10.19401/j.cnki.1007-3639.2025.12.009    

      CLC： R737.9

    • Received：24 November 2025，

      Revised：2025-12-10，

      Published：30 December 2025

    移动端阅览

  • The Society of Breast Cancer China Anti-Cancer Association, Breast Oncology Group of the Oncology Branch of the Chinese Medical Association. Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)[J]. China Oncology, 2025, 35(12): 1157-1255. DOI： 10.19401/j.cnki.1007-3639.2025.12.009.

  •  
  •  

0

Views

225

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Guidelines for breast cancer diagnosis and treatment by China Anti-cancer Association (2024 edition)
China Anti-Cancer Association guideline for diagnosis and treatment of neuroendocrine neoplasms (2025 edition)
China Anti-Cancer Association guideline for diagnosis and treatment of cancer of multiple and unknown primaries (2023 edition)
China Anti-Cancer Association guideline for diagnosis and treatment of neuroendocrine neoplasm (2022 edition)
Exploration of the efficacy and safety of indocyanine green in the evaluation and localization of breast cancer surgical margins: a single-center, observational cohort study

Related Author

Breast Cancer China Anti-Cancer Association The Society of
of the Oncology Branch of the Chinese Medical Association Breast Oncology Group
of Neuroendocrine Neoplasm of China Anti-Cancer Association Society
Society of Cancer of Multiple and Unknown Primary of China Anti-Cancer Association Yuguang
of Neuroendocrine Neoplasm of China Anti-Cancer Association Society
Gang LÜ
Guangqing WANG
Yan ZHENG

Related Institution

Department of Thyroid and Breast Surgery, The Fourth Affiliated Hospital of Anhui Medical University (Affiliated Chaohu Hospital)
Pathology Department, The Fourth Affiliated Hospital of Anhui Medical University (Affiliated Chaohu Hospital)
General Practice, Hefei First People’s Hospital
Department of Nuclear Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine
Department of Oncology, Affiliated Sixth People's Hospital, Shanghai Jiao Tong University
0